SCHEMBL27020187

SCHEMBL27020187

CC1(c2ncc(N=C(c3ccccc3)c3ccccc3)cc2Cl)CC1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 3/20 0.35
ESR2 Q92731 3/20 0.35
CCR1 P32246 1/20 0.33
OPRD1 P41143 1/20 0.32
CYP1A2 P05177 1/20 0.32
CYP3A4 P08684 1/20 0.32
CYP2D6 P10635 1/20 0.32
CYP2C9 P11712 1/20 0.32
CYP2C19 P33261 1/20 0.32
NPSR1 Q6W5P4 1/20 0.32
KDM4E B2RXH2 1/20 0.31
KDM6B O15054 1/20 0.31
TET3 O43151 1/20 0.31
KDM4A O75164 1/20 0.31
KDM4B O94953 1/20 0.31
KDM5A P29375 1/20 0.31
KDM5C P41229 1/20 0.31
KDM4D Q6B0I6 1/20 0.31
TET2 Q6N021 1/20 0.31
TET1 Q8NFU7 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29882420 0.83 ESR1 (0.34) ESR1ESR2CCR1CYP1A2CYP3A4
SCHEMBL23609336 0.83 ESR1 (0.34) ESR1ESR2CCR1CYP1A2CYP3A4
SCHEMBL23608407 0.78 CCR1 (0.31) CCR1
SCHEMBL27020067 0.74 ESR1 (0.37) ESR1ESR2CYP1A2CYP3A4CYP2D6
SCHEMBL25204480 0.71 ALDH1A1 (0.43) ESR1ESR2CYP1A2CYP3A4CYP2D6
SCHEMBL29818274 0.71 ALDH1A1 (0.43) ESR1ESR2CYP1A2CYP3A4CYP2D6
SCHEMBL23580215 0.71 ESR1 (0.38) ESR1ESR2CYP1A2CYP3A4CYP2C9
SCHEMBL29818479 0.71 ESR1 (0.35) ESR1ESR2KDM4EKMT2ANPFFR1
SCHEMBL25742571 0.71 ESR1 (0.35) ESR1ESR2KDM4EKMT2ANPFFR1
SCHEMBL23580114 0.70 GLA (0.40) ESR1ESR2KMT2ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240018157-A1 CYCLIC COMPOUNDS AND METHODS OF USING SAME SCHRÖDINGER, INC. 2024-01-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240018157-A1 CYCLIC COMPOUNDS AND METHODS OF USING SAME MALT1, FKBP1B, FKBP1A ESR1 4729/4885ESR2 4315/4885CCR1 220/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.